BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Importantly, b‐AP15 was toxic to PBMCs from CML patients and synergistically induced cell apoptosis with imatinib on BCR‐ABLWT and BCR‐ABLT315I CML cells.